Joseph Frank Oldakowski
CIK: 0002128814
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CLOVER HEALTH INVESTMENTS, CORP. /DE
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Sep 16, 2026CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
Sale(S)Direct3.2K shares at avg. $4.64$15K - Sep 14, 2026CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
Sale(S)Direct20K shares at avg. $5.16$103K - Jun 16, 2026CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
Sale(S)Direct12.1K shares at avg. $4.86$59K
1-3 of 3 transactions
About OLDAKOWSKI JOSEPH FRANK
OLDAKOWSKI JOSEPH FRANK (SEC CIK 0002128814) files insider reports with the SEC as VP OF FINANCE AND CONTROLLER of CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV).
Signal8 holds 4 ownership filings by OLDAKOWSKI JOSEPH FRANK (1 Form 3, 3 Form 4), filed between Apr 9, 2026 and Sep 17, 2026. Those filings report 3 transactions, from Jun 16, 2026 to Sep 16, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on OLDAKOWSKI JOSEPH FRANK's filings is in WILMINGTON, DE.
Recent filings by OLDAKOWSKI JOSEPH FRANK
Other insiders filing for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
- Soares Karen, Chief Legal Officer
- Reynoso Jamie L., CEO, Medicare Advantage
- Toy Andrew, Chief Executive Officer
- THORNTON JOSEPH CLAY, Interim CFO
- Wai Conrad, CEO, Counterpart Health
- Miller Brian James, Director